c-FMS (CSF1R, CSF-1R) is a receptor protein-tyrosine kinase of the platelet-derived growth factor receptor (PDGFR) family. The cell surface receptor for IL-34 and CSF1 is called c-FMS. Important functions of c-FMS include regulating haematopoiesis, cell survival, maturation of microglia and monocytes, and immune response regulation.
Osteoclasts and myelomonocytic-lineage cells, like monocytes and macrophages, express c-FMS specifically, and the activation of c-FMS signaling encourages the proliferation or differentiation of these cells. Additionally, it encourages the production of inflammatory mediators like interleukin 6 (IL6) and tumor necrosis factor-alpha (TNF-).
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V14353 | Pexidartinib HCl | 2040295-03-0 | Pexidartinib HCl (formerly also know as PLX-3397 HCl) is a novel, orally bioavailable, potent multi-targeted receptor tyrosine kinase inhibitor of CSF-1R, Kit, and Flt3 with IC50 of 20 nM, 10 nM and 160 nM, respectively. |
|
V69271 | Pimicotinib (ABSK021) | 2253123-16-7 | Pimicotinib is a CSF1R inhibitor (antagonist) with anti-tumor activity. |
|
V5141 | PLX-647 | 873786-09-5 | PLX-647 (PLX647) is a novel, potent and highly specific dual FMS/KIT kinase inhibitor with anticancer activity. |
|
V16640 | PLX5622 fumarate | PLX5562 is a highly selective, orally bioactive and CNS-penetrant CSF1R inhibitor. | |
|
V69285 | PLX647 dihydrochloride | 1779796-38-1 | PLX647 di-HCl is an orally bioactive, specific dual kinase inhibitor of FMS and KIT with IC50 of 28 and 16 nM, respectively. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
